Abstract
Receptors for thyrotropin-releasing hormone (TRH) are present on mouse pituitary thyrotropic tumor cells. Incubation of thyrotropes with 100 nM TRH or 4 nM L-triiodothyronine (T3) for 48 h decreased the number of TRH receptors to approximately equal to 50 and 20% of control, respectively. There was no effect on the equilibrium dissociation constant which was 3-5 nM. The depletion in the number of available TRH receptors was time- and dose-dependent. TRH, 100 nM, decreased the receptor number to 70% after 24 h, 50% after 48 h, and 45% of control after 72 h. T3, 4 nM, decreased the receptor number to 52% after 24 h, 20% after 48 h, and 17% of control after 72 h. After 48 h, half-maximal depletion occurred with 1-2 nM TRH and approximately equal to 0.15 nM T3. Incubation with 100 nM TRH and 4 nM T3 caused a significantly greater reduction in the receptor level than either hormone alone. The decrease in the receptor level was reversible within 72 h after removal of TRH, 100 nM, but was only partially reversed, from 20 to 40% of control, after removal of T3, 4 nM, after 120 h. By regulating the number of available TRH receptors on the thyrotrope. TRH and T3 interact to control thyrotropin release.
Full text
PDF![937](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/694872339817/jcinvest00671-0039.png)
![938](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/a401634347c9/jcinvest00671-0040.png)
![939](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/37c0e339b5a3/jcinvest00671-0041.png)
![940](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/5c32833693da/jcinvest00671-0042.png)
![941](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/e51168da8fcf/jcinvest00671-0043.png)
![942](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/57d5f2856cef/jcinvest00671-0044.png)
![943](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f0/371851/a9549573acb4/jcinvest00671-0045.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blackman M. R., Gershengorn M. C., Weintraub B. D. Excess production of free alpha subunits by mouse pituitary thyrotropic tumor cells in vitro. Endocrinology. 1978 Feb;102(2):499–508. doi: 10.1210/endo-102-2-499. [DOI] [PubMed] [Google Scholar]
- Bowers C. Y., Schally A. V., Reynolds G. A., Hawley W. D. Interactions of L-thyroxine or L-triiodothyronine and thyrotropin-releasing factor on the release and synthesis of thyrotropin from the anterior pituitary gland of mice. Endocrinology. 1967 Oct;81(4):741–747. doi: 10.1210/endo-81-4-741. [DOI] [PubMed] [Google Scholar]
- DeMeyts P., Bainco A. R., Roth J. Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem. 1976 Apr 10;251(7):1877–1888. [PubMed] [Google Scholar]
- Eddy L. J., Hershman J. M., Taylor R. E., Jr, Barker S. B. Binding of thyrotropin releasing hormone by thyrotropin-secreting cells. Biochem Biophys Res Commun. 1973 Sep 5;54(1):140–146. doi: 10.1016/0006-291x(73)90900-5. [DOI] [PubMed] [Google Scholar]
- Eto S., Fleischer N. Regulation of thyrotropin (TSH) release and production in monolayer cultures of transplantable TSH-producing mouse tumors. Endocrinology. 1976 Jan;98(1):114–122. doi: 10.1210/endo-98-1-114. [DOI] [PubMed] [Google Scholar]
- Gavin J. R., 3rd, Roth J., Neville D. M., Jr, de Meyts P., Buell D. N. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A. 1974 Jan;71(1):84–88. doi: 10.1073/pnas.71.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gershengorn M. C., Cohen M., Hoffstein S. T. Cellular heterogeneity in primary monolayer cultures of mouse pituitary thyrotropic tumors: separation of thyrotrophs. Endocrinology. 1978 Aug;103(2):648–651. doi: 10.1210/endo-103-2-648. [DOI] [PubMed] [Google Scholar]
- Gershengorn M. C. Regulation of thyrotropin production by mouse pituitary thyrotropic tumor cells in vitro by physiological levels of thyroid hormones. Endocrinology. 1978 Apr;102(4):1122–1128. doi: 10.1210/endo-102-4-1122. [DOI] [PubMed] [Google Scholar]
- Grant G., Vale W., Guillemin R. Characteristics of the pituitary binding sites for thyrotropin releasing factor. Endocrinology. 1973 Jun;92(6):1629–1633. doi: 10.1210/endo-92-6-1629. [DOI] [PubMed] [Google Scholar]
- Grant G., Vale W., Guillemin R. Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. Biochem Biophys Res Commun. 1972 Jan 14;46(1):28–34. doi: 10.1016/0006-291x(72)90625-0. [DOI] [PubMed] [Google Scholar]
- Gual C., Kastin A. J., Schally A. V. Clinical experience with hypothalamic releasing hormones. 1. Thyrotropin-releasing hormone. Recent Prog Horm Res. 1972;28:173–200. [PubMed] [Google Scholar]
- Hinkle P. M., Tashjian A. H., Jr Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture. J Biol Chem. 1973 Sep 10;248(17):6180–6186. [PubMed] [Google Scholar]
- Hinkle P. M., Tashjian A. H., Jr Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in culture. Biochemistry. 1975 Aug 26;14(17):3845–3851. doi: 10.1021/bi00688a017. [DOI] [PubMed] [Google Scholar]
- Hinkle P. M., Woroch E. L., Tashjian A. H., Jr Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. J Biol Chem. 1974 May 25;249(10):3085–3090. [PubMed] [Google Scholar]
- Jacobs L. S., Snyder P. J., Wilber J. F., Utiger R. D., Daughaday W. H. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab. 1971 Dec;33(6):996–998. doi: 10.1210/jcem-33-6-996. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Labrie F., Barden N., Poirier G., De Lean A. Binding of thyrotropin-releasing hormone to plasma membranes of bovine anterior pituitary gland (hormone receptor-adenylate cyclase-equilibrium constant-( 3 H)thyrotropin). Proc Natl Acad Sci U S A. 1972 Jan;69(1):283–287. doi: 10.1073/pnas.69.1.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Léan A. D., Ferland L., Drouin J., Kelly P. A., Labrie F. Modulation of pituitary thyrotropin releasing hormone receptor levels by estrogens and thyroid hormones. Endocrinology. 1977 Jun;100(6):1496–1504. doi: 10.1210/endo-100-6-1496. [DOI] [PubMed] [Google Scholar]
- May P. B., Donabedian R. K. Thyrotropin releasing hormone (TRH) mediated thyroid-stimulating hormone (TSH) release from human anterior pituitary tissue in vitro. J Clin Endocrinol Metab. 1973 Mar;36(3):605–607. doi: 10.1210/jcem-36-3-605. [DOI] [PubMed] [Google Scholar]
- Mukherjee C., Caron M. G., Lefkowitz R. J. Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. Proc Natl Acad Sci U S A. 1975 May;72(5):1945–1949. doi: 10.1073/pnas.72.5.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perrone M. H., Hinkle P. M. Regulation of pituitary receptors for thyrotropin-releasing hormone by thyroid hormones. J Biol Chem. 1978 Jul 25;253(14):5168–5173. [PubMed] [Google Scholar]
- Pollet R. J., Standaert M. L., Haase B. A. Insulin binding to the human lymphocyte receptor. Evaluation of the negative cooperativity model. J Biol Chem. 1977 Aug 25;252(16):5828–5834. [PubMed] [Google Scholar]
- Posner B. I., Kelly P. A., Friesen H. G. Induction of a lactogenic receptor in rat liver: influence of estrogen and the pituitary. Proc Natl Acad Sci U S A. 1974 Jun;71(6):2407–2410. doi: 10.1073/pnas.71.6.2407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shenkman L., Mitsuma T., Hollander C. S. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine. J Clin Invest. 1973 Jan;52(1):205–209. doi: 10.1172/JCI107166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Snyder P. J., Utiger R. D. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest. 1972 Aug;51(8):2077–2084. doi: 10.1172/JCI107014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tashjian A. H., Jr, Barowsky N. J., Jensen D. K. Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem Biophys Res Commun. 1971 May 7;43(3):516–523. doi: 10.1016/0006-291x(71)90644-9. [DOI] [PubMed] [Google Scholar]
- Wilber J. F. Stimulation of 14-C-glucosamine and 14-C-alanine incorporation into thyrotropin by synthetic thyrotropin-releasing hormone. Endocrinology. 1971 Sep;89(3):873–877. doi: 10.1210/endo-89-3-873. [DOI] [PubMed] [Google Scholar]
- Wilber J. F., Utiger R. D. In vitro studies on mechanism of action of thyrotropin releasing factor. Proc Soc Exp Biol Med. 1968 Feb;127(2):488–490. doi: 10.3181/00379727-127-32722. [DOI] [PubMed] [Google Scholar]
- de Meyts P., Roth J., Neville D. M., Jr, Gavin J. R., 3rd, Lesniak M. A. Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun. 1973 Nov 1;55(1):154–161. doi: 10.1016/s0006-291x(73)80072-5. [DOI] [PubMed] [Google Scholar]